Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

522 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The role of anti-thymocyte globulin in allogeneic stem cell transplantation (HSCT) from HLA-matched unrelated donors (MUD) for secondary AML in remission: a study from the ALWP /EBMT.
Nagler A, Labopin M, Kröger N, Schroeder T, Gedde-Dahl T, Eder M, Franke GN, Blau IW, Salmenniemi U, Socie G, Schetelig J, Stelljes M, Ciceri F, Mohty M. Nagler A, et al. Among authors: labopin m. Bone Marrow Transplant. 2023 Dec;58(12):1339-1347. doi: 10.1038/s41409-023-02095-0. Epub 2023 Sep 2. Bone Marrow Transplant. 2023. PMID: 37660157
Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT).
Gorin NC, Labopin M, Fouillard L, Meloni G, Frassoni F, Iriondo A, Brunet Mauri S, Goldstone AH, Harousseau JL, Reiffers J, Esperou-Bourdeau H, Gluckman E. Gorin NC, et al. Among authors: labopin m. Bone Marrow Transplant. 1996 Jul;18(1):111-7. Bone Marrow Transplant. 1996. PMID: 8832003
European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Devergie A, Apperley JF, Labopin M, Madrigal A, Jacobsen N, Carreras E, Prentice HG, Jouet JP, Kolb HJ, Herstenstein B, Bacigalupo A, Evensen SA, Ljungman P, de Witte T, Reiffers J, Nagler A, Clark RE, Goldman JM, Gratwohl A. Devergie A, et al. Among authors: labopin m. Bone Marrow Transplant. 1997 Jul;20(1):11-9. doi: 10.1038/sj.bmt.1700844. Bone Marrow Transplant. 1997. PMID: 9232250
Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Runde V, de Witte T, Arnold R, Gratwohl A, Hermans J, van Biezen A, Niederwieser D, Labopin M, Walter-Noel MP, Bacigalupo A, Jacobsen N, Ljungman P, Carreras E, Kolb HJ, Aul C, Apperley J. Runde V, et al. Among authors: labopin m. Bone Marrow Transplant. 1998 Feb;21(3):255-61. doi: 10.1038/sj.bmt.1701084. Bone Marrow Transplant. 1998. PMID: 9489648 Clinical Trial.
The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Ringdén O, Labopin M, Gorin NC, Meloni G, Blaise D, Reiffers J, Carlson K, Fouillard L, Frassoni F. Ringdén O, et al. Among authors: labopin m. Bone Marrow Transplant. 2000 May;25(10):1053-8. doi: 10.1038/sj.bmt.1702409. Bone Marrow Transplant. 2000. PMID: 10828865
Outcome of 5651 hematopoietic stem cell transplants for hematological malignancies carried out in Europe in 1993: a reliability study of the registry.
Fouillard L, Labopin M, Gratwohl A, Powles R, Bacigalupo A, Bego G, Chesnel V, Gorin NC; European Group for Blood and Marrow Transplantation (EBMT). Fouillard L, et al. Among authors: labopin m. Bone Marrow Transplant. 2002 Nov;30(10):637-43. doi: 10.1038/sj.bmt.1703712. Bone Marrow Transplant. 2002. PMID: 12420201
Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group.
Basara N, Baurmann H, Kolbe K, Yaman A, Labopin M, Burchardt A, Huber C, Fauser AA, Schwerdtfeger R. Basara N, et al. Among authors: labopin m. Bone Marrow Transplant. 2005 May;35(10):1011-8. doi: 10.1038/sj.bmt.1704957. Bone Marrow Transplant. 2005. PMID: 15821768
Results of genoidentical hemopoietic stem cell transplantation with reduced intensity conditioning for acute myelocytic leukemia: higher doses of stem cells infused benefit patients receiving transplants in second remission or beyond--the Acute Leukemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation.
Gorin NC, Labopin M, Boiron JM, Theorin N, Littlewood T, Slavin S, Greinix H, Cahn JY, Alessandrino EP, Rambaldi A, Nagler A, Polge E, Rocha V; Acute Leukemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation. Gorin NC, et al. Among authors: labopin m. J Clin Oncol. 2006 Aug 20;24(24):3959-66. doi: 10.1200/JCO.2006.05.5855. Epub 2006 Jul 31. J Clin Oncol. 2006. PMID: 16880451
522 results